Quarterly report pursuant to Section 13 or 15(d)

Investment in Saneron CCEL Therapeutics, Inc. ("Saneron") - Additional Information (Detail)

v3.5.0.2
Investment in Saneron CCEL Therapeutics, Inc. ("Saneron") - Additional Information (Detail)
 3 Months Ended 6 Months Ended 12 Months Ended
May 31, 2016
USD ($)
Nov. 30, 2015
USD ($)
May 31, 2015
USD ($)
May 31, 2016
USD ($)
Installment
May 31, 2015
USD ($)
Nov. 30, 2014
USD ($)
Installment
Schedule of Equity Method Investments [Line Items]            
Equity method investment $ 0     $ 0    
Equity in losses     $ (8,248)   $ (16,496)  
Saneron [Member]            
Schedule of Equity Method Investments [Line Items]            
Ownership interest 33.00% 33.00%   33.00%    
Equity method investment   $ 0        
Impairment of investment in Saneron   $ 684,000        
Loan Saneron in quarterly payments an aggregate amount $ 300,000     $ 300,000    
Initial loan amount 150,000     $ 150,000    
Additional quarterly payments | Installment       0   5
Date of maturity       5 years    
First initial quarterly payment           $ 37,500
Saneron [Member] | Stock Awards [Member]            
Schedule of Equity Method Investments [Line Items]            
Equity in losses 0   $ 8,248 $ 0 $ 16,496  
Saneron [Member] | Initial Loan [Member]            
Schedule of Equity Method Investments [Line Items]            
Additional quarterly payments | Installment       4    
Quarterly installments per quarter 37,500     $ 37,500    
Saneron [Member] | Additional Loan [Member]            
Schedule of Equity Method Investments [Line Items]            
Initial loan amount 150,000     $ 150,000    
Additional quarterly payments | Installment       4    
Quarterly installments per quarter $ 37,500     $ 37,500